Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK, et al
They require a prescription, a clinical evaluation, and ongoing monitoring to use safely and effectively
That is not a healthy goal
While existing trials suggest higher effectiveness of tirzepatide compared to semaglutide for inducing weight loss, head-to-head trials for patients with overweight or obesity are not yet available
I voted yes because its time to put this decision back in the hands of the patient, the physician and the pharmacist, said David Pope, chief pharmacy officer of Xifin Pharmacy Solutions, after the vote on BPC-157
: ()